Skip to content

Clinical trials

Phase 3 Thromboembolism trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thromboembolism Phase: Phase 3 Country / region: China Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20081
20091
20121
20142
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
Boehringer Ingelheim2
Daiichi Sankyo1
GlaxoSmithKline1
Population Health Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thromboembolism8
Ischemic Attack, Transient2
Pulmonary Embolism2
Stroke2
Thrombosis2
Venous Thromboembolism2
Venous Thrombosis2
Atrial Fibrillation1
Cerebrovascular Disorders1
Hemorrhage1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.